Provided by Tiger Fintech (Singapore) Pte. Ltd.

Replimune Group Inc.

7.03
-0.5200-6.89%
Pre-market: 6.87-0.1600-2.28%07:41 EDT
Volume:19.69M
Turnover:139.37M
Market Cap:546.98M
PE:-2.29
High:7.62
Open:6.93
Low:6.67
Close:7.55
Loading ...

Why Is Replimune Stock (NASDAQ:REPL) Exploding?

TIPRANKS
·
Yesterday

Replimune Group Raised to Overweight From Neutral by Cantor Fitzgerald

Dow Jones
·
Yesterday

Replimune upgraded to Overweight at Cantor after Prasad leaves FDA

TIPRANKS
·
Yesterday

Replimune upgraded to Overweight from Neutral at Cantor Fitzgerald

TIPRANKS
·
Yesterday

Replimune Group Soars Following FDA Official's Departure

Stock Track
·
30 Jul

Replimune Group Inc. Announces Date for 2025 Annual Meeting of Stockholders

Reuters
·
26 Jul

HC Wainwright Downgrades Replimune to Neutral From Buy

MT Newswires Live
·
23 Jul

Replimune Group (REPL) was downgraded to a Hold Rating at H.C. Wainwright

TIPRANKS
·
23 Jul

Replimune downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
23 Jul

U.S. RESEARCH ROUNDUP-Boot Barn Holdings, Coca-Cola, Honeywell

Reuters
·
23 Jul

Why Is Replimune Stock (REPL) Down 75% Today?

TIPRANKS
·
23 Jul

Stock Track | Replimune Group Rebounds 5.53% After 75% Plunge on FDA Rejection

Stock Track
·
23 Jul

Replimune downgraded to Equal Weight from Overweight at Barclays

TIPRANKS
·
23 Jul

Top Midday Decliners

MT Newswires Live
·
23 Jul

Replimune Group Cut to Neutral From Overweight by JP Morgan

Dow Jones
·
23 Jul

Replimune Group Is Maintained at Buy by Jefferies

Dow Jones
·
23 Jul

Replimune Group (REPL) Receives a Buy from Leerink Partners

TIPRANKS
·
23 Jul

Replimune downgraded to Market Perform from Outperform at Leerink

TIPRANKS
·
23 Jul

Replimune Group (REPL) Gets a Buy from BMO Capital

TIPRANKS
·
23 Jul

Barclays Remains a Buy on Replimune Group (REPL)

TIPRANKS
·
23 Jul